Compounds > tirofiban
Page last updated: 2024-08-24

tirofiban and Cardiomyopathies, Primary

tirofiban has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, EA; Kamran, M; Kini, AS; Lee, P; Marmur, JD; Perez, N; Richard, M; Sharma, SK; Suleman, J1

Trials

1 trial(s) available for tirofiban and Cardiomyopathies, Primary

ArticleYear
Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).
    The American journal of cardiology, 2002, Sep-01, Volume: 90, Issue:5

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiac Catheterization; Cardiomyopathies; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Incidence; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Necrosis; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Stroke Volume; Tirofiban; Treatment Outcome; Troponin I; Tyrosine

2002